IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: The highly fatal glioblastoma has an extremely poor prognosis and development of a new treatment is desired. Local treatment is limited due to its high invasiveness, and immunotherapy utilizing self-immune mechanism is theoretically expected. An autologous formalin-fixed tumor vaccine (A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurooncol Adv
Hlavní autoři: Nitta, Masayuki, Muragaki, Yoshihiro, Ishikawa, Eiichi, Maruyama, Takashi, Ikuta, Soko, Saito, Taiichi, Tsuzuki, Shunsuke, Fukui, Atsushi, Mastumura, Akira, Kawamata, Takakazu
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213209/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.079
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky